X

Allpennystocks.com Featured Company: Millennium Biotechnologies Inc. (MBTG.OB) Reports 40% Sales Growth in Greek Market

Millennium Biotechnologies has reported 2007 sales figures of their Resurgex line of products in Greece. They finished their year with $50,000 in sales, 40% higher than their 2006 revenues of $30,000. Their successful entry into a tough market like the one in Greece is largely attributed to their relationship with Nutrimedica. Nutrimedica is a distributor that has preexisting knowledge of Greek regulations, markets and consumers that has allowed Millennium Biotechnolgies to gain access to the right place at the right time.

Resurgex is marketed with three products, Resurgex, Resurgex Plus and Resurgex Select. All three are designed to help cancer patients and others that are undergoing chemotherapy or radiation treatments and need as much help for their recovering bodies as possible. They provide patients with calorie dense, high protein food that is rich in nutrition.

In addition to the large increase in sales of Resurgex, the company is very eager about their newest development, Surgex. Surgex is a sports nutrition formula, clinically proven to address the nutritional concerns of both professional and amateur elite athletes. These athletes often experience similar symptoms post-workout to those battling immune-compromised conditions, such as fatigue, loss of lean muscle, oxidative stress, and reduced immune function. All of these symptoms can be reduced and often eliminated by the use of Surgex and proper training.

Recently Surgex has been endorsed by TEST Sports Clubs because of its use with the nutritional training program for elite college athletes before the NFL Combine. The Surgex formula meets NCAA guidelines for use by collegiate athletes and is certified by The Banned Substances Control Group (BSCG) to contain no banned substances, making it perfectly legal for athletes in all sports at every level.

Let us hear your thoughts below:

Related Post